China NT Pharma Group Company Limited has resolved to appoint CCTH CPA Limited as external auditor, filling the vacancy created by the retirement of Moore CPA Limited announced on 4 June 2026. The engagement is subject to shareholder approval at an upcoming extraordinary general meeting and will run until the conclusion of the next annual general meeting.

The Audit Committee endorsed CCTH after evaluating its audit fee proposal, track record with more than 40 listed companies—including healthcare peers—independence, market reputation, team resources and alignment with guidelines issued by the Accounting and Financial Reporting Council.

The estimated audit fee for the review of the Group’s consolidated financial statements for the year ending 31 December 2026 is approximately RMB0.88 million, excluding out-of-pocket expenses. A circular detailing the proposed appointment and notice of the EGM will be dispatched to shareholders in due course.

The Board stated that engaging CCTH will uphold audit quality and serve the best interests of both the Company and its shareholders.